KLK7 and Fabry disease: A moderate inhibitor (molecule 1, Figure 3) of kallikrein 7 (KLK7), a related S1 serine protease, without any inhibitory activity against human FD in an enzymatic thioesterolysis assay [38], provided the blueprint for the rational design of latent FD inhibitors.